UniSa - IRIS Institutional Research Information System

PERSICO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.243
AS - Asia 2.488
EU - Europa 2.479
SA - Sud America 303
AF - Africa 25
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.174
SG - Singapore 937
CN - Cina 804
UA - Ucraina 629
IT - Italia 550
RU - Federazione Russa 410
BR - Brasile 278
DE - Germania 245
IE - Irlanda 236
VN - Vietnam 217
KR - Corea 192
TR - Turchia 150
FI - Finlandia 147
SE - Svezia 102
HK - Hong Kong 80
CA - Canada 61
GB - Regno Unito 38
FR - Francia 26
DK - Danimarca 25
AT - Austria 23
IN - India 23
JP - Giappone 23
NL - Olanda 20
AU - Australia 11
TW - Taiwan 9
BD - Bangladesh 8
ZA - Sudafrica 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
EC - Ecuador 6
ES - Italia 6
EU - Europa 6
AR - Argentina 5
CO - Colombia 5
MX - Messico 5
PK - Pakistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
UZ - Uzbekistan 4
CH - Svizzera 3
EG - Egitto 3
GR - Grecia 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
HN - Honduras 2
IL - Israele 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
PH - Filippine 1
PL - Polonia 1
PY - Paraguay 1
QA - Qatar 1
UG - Uganda 1
Totale 12.559
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.681
Chandler 838
Jacksonville 819
Princeton 723
Woodbridge 520
Wilmington 366
Houston 295
Singapore 261
Dublin 229
Dong Ket 217
Ashburn 211
Beijing 188
Andover 164
Nanjing 146
Izmir 142
Pellezzano 128
Boardman 120
Moscow 94
Salerno 64
Hong Kong 57
Hebei 55
Shenyang 54
Naples 49
The Dalles 47
Ottawa 46
Fairfield 45
Changsha 44
Nanchang 42
Norwalk 42
Jiaxing 39
Düsseldorf 33
Redwood City 33
Los Angeles 29
Tianjin 29
Jinan 28
Mestre 25
Washington 25
Dallas 23
Nuremberg 23
Falls Church 20
São Paulo 20
Dearborn 19
Guangzhou 19
San Diego 17
Council Bluffs 16
Seattle 16
New York 14
Helsinki 13
Nürnberg 13
Tokyo 13
Belo Horizonte 12
Cambridge 12
Lappeenranta 12
Vienna 12
Zhengzhou 12
Copenhagen 11
Pune 11
Fisciano 10
Jinju 10
London 10
Milan 10
Munich 10
San Mango Piemonte 10
Haikou 9
Maletto 9
Rome 9
Santa Clara 9
Amsterdam 8
Rio de Janeiro 8
Brasília 7
Phoenix 7
Pontecagnano 7
San Giorgio A Cremano 7
San Jose 7
Shanghai 7
Ningbo 6
Saint Petersburg 6
Salvador 6
Shenzhen 6
Bologna 5
Brno 5
Curitiba 5
Frankfurt am Main 5
Ha Kwai Chung 5
Hangzhou 5
Melbourne 5
Napoli 5
Porto Alegre 5
Redmond 5
Tappahannock 5
Auckland 4
Baku 4
Caxias do Sul 4
Chennai 4
Dhaka 4
Dormagen 4
Edmonton 4
Frederiksberg 4
Fuzhou 4
Giugliano In Campania 4
Totale 8.509
Salva come PNG Salva come JPEG
Nome #
Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma 265
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 131
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 124
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 123
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. 117
Coeliac disease and C virus-related chronic hepatitis: a non association 115
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 114
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 107
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 105
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 104
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 103
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 103
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 103
Alcoholic Liver Disease and Hepatitis C Chronic Infection 99
Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). 94
Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. 93
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 93
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 93
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 92
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 92
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 91
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 91
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 90
Electrophysiological evidence for Na+-coupled bicarbonate transport in cultured rat hepatocytes 89
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy 89
Risk factors for hospital readmission of elderly patients. 89
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 87
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma 86
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? 86
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 84
[Diabetic neuropathies. IV. Autonomous neuropathy. Peripheral sympathetic innervation and the cardiovascular system]. 82
Pharmacotherapy of alcoholic liver disease in clinical practice 82
Epidemiology and Natural History of Alcoholic Liver Disease 82
Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. 81
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. 81
154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY 81
A randomised controlled trial on pegylated interferon alfa-2a (40kd)(Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 80
A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection. 79
478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 79
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 79
FN 44 HEPATIC RETINOL BINDING PROTEIN 4 (RBP-4) LEVELS ARE SIGNIFICANTLY RELATED TO THE STEATOHEPATITIS GRADE (COMPROMISSION) BUT NOT WITH HCV INFECTION 78
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 78
The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction 78
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 78
Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: Results of a prospective multicentric study 77
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C 76
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 76
Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions. 76
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 75
Na+-H+ exchange activity in rat hepatocytes: Role in regulation of intracellular pH 75
Steatosis as a co-factor in chronic liver diseases 75
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 74
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 74
Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis. 73
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. 73
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis 73
Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. 72
Alanine aminotransferase measurements and histological disease in hepatitis C. 72
Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. 71
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease 71
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 71
Non Alcoholic Fatty Liver: Epidemiology and Natural History 71
Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. 70
Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. 70
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 70
Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. 69
Erratum to: HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas 69
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. 68
Long-term liver histology improvement in patients with chronic hepatitis B and sustained response to interferon 68
The importance of HCV on burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases 68
Clinical management of HCV carriers with normal aminotransferase levels. 67
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. 67
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas 67
Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. 67
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 67
Dose dependence of nicotinic acid-induced hyperbilirubinemia and its dissociation from hemolysis in Gilbert's syndrome. 66
Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. 66
Improvement of the nicotinic acid test in the diagnosis of Gilbert's syndrome by pretreatment with indomethacin. 66
Interference of diet on liver histology and on the response to interferon therapy in patients with HCV-related chronic liver disease 66
The clinical significance of occult HBV infection in acute delta virus hepatitis in a case of immunosuppressive therapy for non-Hodgkin lymphomas. 66
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 66
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial. 66
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. 65
Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospective study. 65
Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma. 65
Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study 65
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 65
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 65
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 63
Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis. 63
Sex steroid modulation of the hepatic uptake of organic anions in rat. 62
HCV infection and hepatocellular carcinoma in cirrhotics: what is the linkage? 62
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach]. 62
P. 253 Rapid virological response in genotype 1b patients treated with peginterferon plus ribavirin: evidence for a significant sustained virological response (SVR) after 24 weeks of therapy in peg-interferon-alpha-2a treated patients 62
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 62
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy 62
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. 61
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels 61
NASH is a peculiar pathological expression of insulin-resistance 61
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea 61
Totale 8.076
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020279 0 0 0 0 0 0 0 0 0 0 223 56
2020/20211.291 52 126 139 20 149 52 160 13 135 12 180 253
2021/20221.248 6 3 8 6 26 24 34 58 193 169 156 565
2022/20232.009 207 118 63 237 291 430 12 185 301 5 108 52
2023/2024890 82 120 69 32 71 140 32 44 8 34 51 207
2024/20252.320 73 46 56 118 152 290 434 323 486 170 172 0
Totale 12.927